Why the study?
Does AAV-9 microdystrophin gene therapy improve electrocardiographic abnormalities in a mouse model of Duchenne muscular dystrophy?
Population
Neonatal mdx mice and normal C57BL/10SnJ mice.
Comparison
A single intravenous injection of AAV serotype-9… vs Untreated mdx mice and normal BL10 mice.
Design
Preclinical
Follow-up
4 months
Authors
Loading...
Hypothesis-generating in mdx mice; leaves open translation of AAV-9 microdystrophin to human DMD conduction disease.
Does AAV-9 microdystrophin gene therapy improve electrocardiographic abnormalities in a mouse model of Duchenne muscular dystrophy?
AAV-9 microdystrophin gene therapy efficiently transduces the heart and ameliorates early electrocardiographic abnormalities in a mouse model of Duchenne muscular dystrophy.
Yue et al. (2008) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: